Transcriptionally, ZMYND8 can target oncogenes, multi-drug resistance genes, and stemness genes in breast cancer that are maintained in a poised epigenetic state and can repress them in association with KDM5C and EZH2 [24]. This evidence concerns the gene ZMYND8 and breast carcinoma.